Why Adaptimmune Therapeutics (ADAP) Stock Is Moving
Why Adaptimmune Therapeutics (ADAP) Stock Is Moving
Adaptimmune Therapeutics PLC – ADR (NASDAQ:ADAP) shares are trading higher by 15.8% to $1.17 during Friday's session after the company and Galapagos entered a clinical collaboration to license Adaptimmune's uza-cel in head & neck cancer.
Adaptimmune Therapeutics PLC — ADR（納斯達克股票代碼：ADAP）股價在週五的交易中上漲了15.8％，至1.17美元，此前該公司與加拉帕戈斯進行了臨床合作，爲Adaptimmune的uza-cel發放了頭頸癌許可。
Uza-cel, which has shown an 80% response rate in a Phase 1 trial, is engineered to express the CD8α co-receptor, enhancing the immune response against tumors.
UZA-cel在1期試驗中顯示出80％的反應率，其設計目的是表達CD8α輔助受體，從而增強對腫瘤的免疫反應。
The collaboration will utilize Galapagos' decentralized cell manufacturing platform, which may improve the efficacy and durability of uza-cel and enable faster treatment delivery, with a vein-to-vein time of seven days.
此次合作將利用加拉帕戈斯的分散式細胞製造平台，該平台可以提高uza-cel的療效和耐久性，並加快治療交付，靜脈到靜脈的時間爲七天。
How To Buy ADAP Stock
如何購買 ADAP 股票
Besides going to a brokerage platform to purchase a share – or fractional share – of stock, you can also gain access to shares either by buying an exchange traded fund (ETF) that holds the stock itself, or by allocating yourself to a strategy in your 401(k) that would seek to acquire shares in a mutual fund or other instrument.
除了前往經紀平台購買股票的股票（或部分股票）外，您還可以通過購買本身持有股票的交易所交易基金（ETF）來獲得股票，或者將自己分配到401（k）中尋求收購共同基金或其他工具股票的策略。
For example, in Adaptimmune Therapeutics' case, it is in the Health Care sector. An ETF will likely hold shares in many liquid and large companies that help track that sector, allowing an investor to gain exposure to the trends within that segment.
例如，就Adaptimmune Therapeutics而言，它屬於醫療保健領域。ETF可能會持有許多有助於追蹤該行業的流動性和大型公司的股票，從而使投資者能夠了解該細分市場的趨勢。
According to data from Benzinga Pro, ADAP has a 52-week high of $2.05 and a 52-week low of $0.42.
根據Benzinga Pro的數據，ADAP的52周高點爲2.05美元，52周低點爲0.42美元。
譯文內容由第三人軟體翻譯。